<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Liang SH</submitter><funding>NIDA NIH HHS</funding><pagination>1025-9</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4569883</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>6(9)</volume><pubmed_abstract>Zinc, copper, and iron ions are involved in amyloid-beta (Aβ) deposition and stabilization in Alzheimer's disease (AD). Consequently, metal binding agents that prevent metal-Aβ interaction and lead to the dissolution of Aβ deposits have become well sought therapeutic and diagnostic targets. However, direct intervention between diseases and metal abnormalities has been challenging and is partially attributed to the lack of a suitable agent to determine and modify metal concentration and distribution in vivo. In the search of metal ionophores, we have identified several promising chemical entities by strategic fluorination of 8-hydroxyquinoline drugs, clioquinol, and PBT2. Compounds 15-17 and 28-30 showed exceptional metal ionophore ability (6-40-fold increase of copper uptake and >2-fold in</pubmed_abstract><journal>ACS medicinal chemistry letters</journal><pubmed_title>Novel Fluorinated 8-Hydroxyquinoline Based Metal Ionophores for Exploring the Metal Hypothesis of Alzheimer's Disease.</pubmed_title><pmcid>PMC4569883</pmcid><funding_grant_id>K01 DA038000</funding_grant_id><pubmed_authors>Fraser BH</pubmed_authors><pubmed_authors>Greguric I</pubmed_authors><pubmed_authors>Liang SH</pubmed_authors><pubmed_authors>Shoup TM</pubmed_authors><pubmed_authors>Southon AG</pubmed_authors><pubmed_authors>Krause-Heuer AM</pubmed_authors><pubmed_authors>Vasdev N</pubmed_authors><pubmed_authors>Bush AI</pubmed_authors><pubmed_authors>Han Y</pubmed_authors><pubmed_authors>Lewis R</pubmed_authors><pubmed_authors>Zhang B</pubmed_authors><pubmed_authors>Volitakis I</pubmed_authors></additional><is_claimable>false</is_claimable><name>Novel Fluorinated 8-Hydroxyquinoline Based Metal Ionophores for Exploring the Metal Hypothesis of Alzheimer's Disease.</name><description>Zinc, copper, and iron ions are involved in amyloid-beta (Aβ) deposition and stabilization in Alzheimer's disease (AD). Consequently, metal binding agents that prevent metal-Aβ interaction and lead to the dissolution of Aβ deposits have become well sought therapeutic and diagnostic targets. However, direct intervention between diseases and metal abnormalities has been challenging and is partially attributed to the lack of a suitable agent to determine and modify metal concentration and distribution in vivo. In the search of metal ionophores, we have identified several promising chemical entities by strategic fluorination of 8-hydroxyquinoline drugs, clioquinol, and PBT2. Compounds 15-17 and 28-30 showed exceptional metal ionophore ability (6-40-fold increase of copper uptake and >2-fold in</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Sep</publication><modification>2026-04-18T07:35:56.934Z</modification><creation>2026-04-07T14:36:05.449Z</creation></dates><accession>S-EPMC4569883</accession><cross_references><pubmed>26396692</pubmed><doi>10.1021/acsmedchemlett.5b00281</doi></cross_references></HashMap>